Business

Holding in Company

Holding in Company.

articleRua Life Sciences PlcAugust 6, 20075/company/rua-life-sciences-plc/news/holding-in-company-15
Holding in Company

About this update from Rua Life Sciences Plc

[{"type":"text","content":"\n Aortech International PLC\n06 August 2007\n\n\nTR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES\n\n\n1. Identity of the issuer or the underlying issuer of existing shares to which\nvoting rights are attached (ii):\n\nAorTech International plc\n\n\n2. Reason for the notification (please state Yes/No): ( )\n\nAn acquisition or disposal of voting rights: ( Yes )\nAn acquisition or disposal of financial instruments which may result in the\nacquisition of shares already issued to which voting rights are attached: ( )\nAn event changing the breakdown of voting rights: ( )\nOther (please specify): ( )\n\n\n3. Full name of person(s) subject to the notification obligation (iii):\n\nMF Global UK Limited\n\n\n4. Full name of shareholder(s) (if different from 3.) (iv):\n\nN/A\n\n\n5. Date of the transaction (and date on which the threshold is crossed or\nreached if different) (v):\n\n02 August 2007\n\n\n6. Date on which issuer notified:\n\n03 August 2007\n\n\n7. Threshold(s) that is/are crossed or reached:\n\n3%\n\n\n8. Notified details:\nA: Voting rights attached to shares\n\nClass/type of shares if possible using Situation previous to the Triggering\nthe ISIN CODE transaction (vi)\n\n Number of Number of\n shares voting Rights\n (viii)\n\nGB0033360586 Below 3% Below 3%\n\n\nResulting situation after the triggering transaction (vii)\n\nClass/type of shares if Number of Number of voting rights % of voting\npossible using the ISIN shares (ix) rights\nCODE\n Direct Direct (x) Indirect (xi) Direct Indirect\n\nGB0033360586 114,568 114,568 114,568 \n\n\nB: Financial Instruments\n\nResulting situation after the triggering transaction (xii)\nType of Expiration Exercise/ Number of voting rights that may % of\nfinancial Date Conversion be acquired if the instrument is voting\ninstrument (xiii) Period/Date exercised/ converted. rights\n (xiv)\n\nN/A N/A N/A N/A N/A\n\n\nTotal (A+B)\n\nNumber of voting rights % of voting rights \n \n 114,568 3.01%\n\n\n9. Chain of controlled undertakings through which the voting rights and/or the\nfinancial instruments are effectively held, if applicable (xv):\n\nn/a\n\n\nProxy Voting:\n\n10. Name of the proxy holder:\n\nn/a\n\n\n11. Number of voting rights proxy holder will cease to hold:\n\nn/a\n\n\n12. Date on which proxy holder will cease to hold voting rights:\n\nn/a\n\n\n13. Additional information:\n\n\nn/a...

More updates from Rua Life Sciences Plc